FDA allows reformulated ranitidine back on the market
Regulatory NewsFerdous Al-Faruque
GenericsPharmaceuticalsRegulatory Intelligence/PolicySafety communicationUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueGenericsPharmaceuticalsRegulatory Intelligence/PolicySafety communicationUnited StatesUS Food and Drug Administration (FDA)